ReviewEuropean radiology2010
Partial "targeted" embolisation of brain arteriovenous malformations.
Review in European radiology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
35 citing papers in PubMed.
- Ruptured brain arteriovenous malformations associated with aneurysms: safety and efficacy of selective embolization in the acute phase of hemorrhage.Neuroradiology · 2014Trial
- Curative embolization of brain arteriovenous malformations with onyx: patient selection, embolization technique, and results.AJNR. American journal of neuroradiology · 2012Trial
- Treatment patterns and outcomes in elderly patients with brain arteriovenous malformations: a multicenter prospective cohort study.BMC geriatrics · 2026Article
- Overcoming the Challenge of Distal Lenticulostriate Artery Aneurysms With Transarterial Embolization: Technical Insights, Case Series, and Literature Review.Neurosurgery practice · 2025Review
- Paroxysmal sympathetic hyperactivity and cerebral salt wasting post management of arteriovenous malformation in a pediatric patient: A case report.Surgical neurology international · 2025Article
- Analysis of the role of perfusion parameters in predicting rupture of brain arteriovenous malformations: a multi-center study.Scientific reports · 2024Article
- Considerations for the Use of Stereotactic Radiosurgery to Treat Large Arteriovenous Malformations.Biomedicines · 2024Review
- Article
- Angiographic predictors of spontaneous obliteration of transarterial partially embolized brain arteriovenous malformations.Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences · 2023Article
- Clinical features and outcome in pediatric arteriovenous malformation: institutional multimodality treatment.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2023Article
- Clinico-radiological features of cerebral proliferative angiopathy: A large case series from India.The neuroradiology journal · 2022Article
- New aneurysm formation and regrowth associated with rebleeding of residual pediatric ruptured arteriovenous malformation: patient series.Journal of neurosurgery. Case lessons · 2022Article
- Chinese Cerebrovascular Neurosurgery Society and Chinese Interventional & Hybrid Operation Society, of Chinese Stroke Association Clinical Practice Guidelines for Management of Brain Arteriovenous Malformations in Eloquent Areas.Frontiers in neurology · 2021Review
- Targeted endovascular treatment for ruptured brain arteriovenous malformations.Neurosurgical review · 2020Review
- S-shaped distal access catheter supported microcatheter navigation into the lenticulostriate artery feeders of brain arteriovenous malformations.Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences · 2020Article
- Pre-Surgical Endovascular Proximal Feeder Artery Devascularization Technique for the Treatment of Cranial Arteriovenous Malformations.Vascular health and risk management · 2020Article
- High sensitivity and specificity of 4D-CTA in the detection of cranial arteriovenous shunts.European radiology · 2019Observational
- Vessel wall enhancement of a ruptured intra-nidal aneurysm in a brain arteriovenous malformation.Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences · 2019Article
- Targeted Embolization of Aneurysms Associated With Brain Arteriovenous Malformations at High Risk for Surgical Resection: A Case-Control Study.Neurosurgery · 2018Article
- Rendering a ruptured arteriovenous malformation more susceptible to spontaneous obliteration as a possible treatment strategy for cerebral AVM.Journal of surgical case reports · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The treatment of pial arteriovenous brain malformations is controversial. Little is yet known about their natural history, their pathomechanisms and the efficacy and risks of respective proposed treatments. It is known that only complete occlusion of the AVM can exclude future risk of haemorrhage and that the rates of curative embolisation of AVMs with an acceptable periprocedural risk are around 20 to 50%. As outlined in the present article, however, partial, targeted embolisation also plays a role. In acutely ruptured AVMs where the source of bleeding can be identified, targeted embolisation of this compartment may be able to secure the AVM prior to definitive treatment. In unruptured symptomatic AVMs targeted treatment may be employed if a defined pathomechanism can be identified that is related to the clinical symptoms and that can be cured with an acceptable risk via an endovascular approach depending on the individual AVM angioarchitecture. This review article gives examples of pathomechanisms and angioarchitectures that are amenable to this kind of treatment strategy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.